Drug Safety and Risk Management Advisory Committee Archives

Alkermes’ Schizophrenia Drug Passes FDA Advisory Committee Hurdle

Advisory Committees, Clinical Trials, Drug Safety and Risk Management Advisory Committee, FDA, PDUFA, Psychopharmacologic Drugs Advisory Committee, R&D, Schizophrenia

Shares of Alkermes were up in trading after the Ireland-based company announced the experimental schizophrenia drug ALKS 3831 was overwhelmingly supported by an advisory committee for the U.S. Food and Drug Administration.

October 12, 2020/by Andrew Humphreys